archive-com.com » COM » I » ISIS-INNOVATION.COM

Total: 451

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Molecular and Cellular Medicine Board (MCMB) - Isis Innovation
    Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Molecular and Cellular Medicine Board MCMB Share this Molecular and Cellular Medicine Board MCMB Work on basic biological mechanisms or technology relevant to understanding aetiology of or developing treatments for multiple diseases or conditions excluding particular organ systems or diseases Also large multi purpose cohort studies linking genetics or other biological measures to environment and health Molecular and Cellular Medicine Board Key points focus MCMB is responsible for the MRC s programmes and funding in Cell biology Structural biology and biophysics Developmental and stem cell biology excluding neurobiology Molecular haematology Chemical biology Bioinformatics Cancer includes basic biology translational research and epidemiology Radiation Oncology and Biology Genetic mechanisms and genomics Toxicology Environmental factors toxins radiation etc affecting health Pharmacology Regenerative medicine Nanotechnology and applications of other new technologies to biomedicine Method development for gene therapy Applications relating to particular organ systems or diseases with the exception of cancer leukaemia and molecular haematology should be normally directed to MRC s other research boards The board is also responsible for MRC s investment in large multi purpose cohort studies linking genetics or other biological measures to environment and health such as UK Biobank and ALSPAC although project applications to use these resources for studies of particular diseases should be directed to the relevant board Other comments All proposals anticipating MRC expenditure greater than 3 million should be discussed with the named Programme Manager Applications Procedure Please note that all applicants are required to select the generic Research Board Submissions Call e g Research Boards Jan Feb 2014 Submissions during the process of creating their New Document within the Je S System Type of fund Other sources of translational funding Institute Awarding Body Amount 3 000 000 Closing date for applications 10th September 2014 Next Call for Applications Call opens 30 July 2014 Deadline for submissions 10 September 2014 Board meeting 18 19 February 2015 MRC reserves the right to change the date of calls and recommends that you check the

    Original URL path: http://isis-innovation.com/award-details/molecular-cellular-medicine-board-mcmb/ (2016-05-01)
    Open archived version from archive


  • Infections and Immunity Research Board (IIB) - Isis Innovation
    Other Languages Contact us Technologies Available Explore Technologies for License Intellectual Property IP for SMEs Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Infections and Immunity Research Board IIB Share this Infections and Immunity Research Board IIB Basic clinical and translational research applied to infectious human disease and disorders of the human immune system Priorities include accelerating vaccines research advancing understanding of human immunology public health infections microbiology and antimicrobial resistance and global health partnerships Infections and Immunity Research Board Key points focus IIB is responsible for the MRC s programmes and funding in Virology bacteriology and parasitology of human pathogens zoonoses model infectious agents and vectors of infectious agents Human immunology including studies in humans and informative models Molecular cellular and systems research into mechanisms of susceptibility immunity

    Original URL path: http://isis-innovation.com/award-details/infections-immunity-research-board-iib/ (2016-05-01)
    Open archived version from archive

  • Populations and Systems Medicines Board - Isis Innovation
    For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Populations and Systems Medicines Board Share this Populations and Systems Medicines Board PSMB wishes to encourage high quality proposals in translational and clinical research especially in musculoskeletal research respiratory medicine integrative physiology population health sciences Population and Systems Medicines Board Key points focus Funds work on function and pathophysiology and prevention or treatment of deterioration or illness in all the major organ systems except the brain including cardiovascular musculoskeletal gastrointestinal respiratory endocrine reproductive nutrition energy metabolism obesity diabetes ageing and lifelong health maternal health and the early origins of health and disease medical sociology trauma acute medicine and surgery lifestyle socio economic and behavioural impacts on general health and health inequalities Other comments PSMB wishes to encourage high quality proposals in translational and clinical research especially in musculoskeletal research in particular research into the maintenance of musculoskeletal health especially where such research could underpin the development of new diagnostic approaches respiratory medicine in particular research into the mechanisms of chronic inflammatory lung disease the early origins of lung disease the aetiology of disease the biological basis for the observed variation in disease progression integrative physiology PSMB has a longstanding interest in research at the levels of organs systems and whole animals with the aim to help promote understanding of normal function and the physiology of disease In an effort to consolidate and strengthen integrative physiology research in the UK the MRC co sponsored a joint workshop with the Wellcome Trust and more recently contributed to a major capacity building initiative in partnership with industry the funding councils and others population health sciences population based studies into the aetiology of disease traditional epidemiology social and behavioural medicine PSMB plays a leading role in supporting most aspects of experimental medicine and clinical research Applications Procedure Please note that all applicants are required to select the generic Research Board Submissions Call e g Research Boards Jan Feb 2014 Submissions during the process of creating their New Document within the Je S System Type of fund Other sources of translational funding Institute Awarding Body Amount 125 000 plus Closing date for applications 30th September 2014 Next Call for Applications Call opens 30 July 2014 Deadline for submissions 30 September 2014

    Original URL path: http://isis-innovation.com/award-details/populations-systems-medicines-board/ (2016-05-01)
    Open archived version from archive

  • Neurosciences and Mental Health - Isis Innovation
    Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Neurosciences and Mental Health Share this Neurosciences and Mental Health Funding for innovative research into how the brain controls our behaviour how it responds to injury and nervous system functioning development of tools and techniques that help others carry out research on the nervous system multidisciplinary research to increase understanding of the brain in health and disease MRC Neurosciences and Mental Health Key points focus Portfolio includes neurodegeneration clinical neurology and neuroinflammation mental health addictions and Substance Misuse behavioural and learning disorders cognitive and behavioural neuroscience and cognitive systems sensory neuroscience vision and hearing neurobiology and neurophysiology underpinning support such as neuroimaging technology brain banking and neuroinformatics CFS ME through population systems medicine Other comments MRC funds innovative research that tells us how the brain controls our behaviour how the nervous system functions throughout life in health and disease and how it responds to injury It also supports the development of tools and techniques that help others carry out research on the nervous system MRC is particularly interested in multidisciplinary research that will increase our understanding of the brain in health and disease Applications Procedure It is the applicant s responsibility to ensure they apply to the correct call board type of grant Applicants must read and understand any guidance and if in doubt they should contact the relevant programme manager for that call for further information Incorrect selection will incur significant delay and is very likely to cause deferral to a later meeting typically a delay of 4 months or more For some schemes or calls applicants may need to submit Outline proposals before making full proposals Usually feedback will be given at the end of the Outline stage Such feedback is designed to help applicants improve the quality of their subsequent full proposal if invited to strengthen its competitiveness Proposals must be submitted using the Joint electronic Submission System Je S For applications JeS queries email to JeSHelp rcuk ac uk Type of fund Other sources of translational funding Institute Awarding Body Amount

    Original URL path: http://isis-innovation.com/award-details/neurosciences-mental-health/ (2016-05-01)
    Open archived version from archive

  • The Wellcome Trust Translation Fund - Isis Innovation
    to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding The Wellcome Trust Translation Fund Share this The Wellcome Trust Translation Fund Translational funding for projects covering any aspect of technology development from a range of disciplines including physical computational and life sciences Projects must address an unmet need in healthcare applied medical research offer a potential new solution and have a realistic expectation of further development by the market T he Wellcome Trust Translation Fund Key points focus Projects must address an unmet need in healthcare and offer a potential new solution Projects must plan to take the innovation to a stage at which it is sufficiently developed to be attractive to another party such as not for profit organisations and commercial organisations e g venture capital funds pharma biotech Other comments The aim of Translation Awards is to develop innovative and ground breaking new technologies in the biomedical area Projects must have already demonstrated proof of principle supported by experimental data Proposals are welcome from academic and commercial organisations based in the UK and overseas To encourage more applications in underserved and challenging areas the fund will have strategic highlight areas currently mid 2014 Restoring the Body Ground breaking proposals in novel biomedicine are invited proposals that seek to restore function to the body and enable people to lead full and independent lives However projects covering any aspect of technology development from a range of disciplines including physical computational and life sciences will be considered at any time The Trust will normally actively participate in the stewardship of the project and lead on intellectual property management and exploitation Applications Procedure Prospective applicants should complete a concept note and send it to Innovations innovations wellcome ac uk where it will be considered internally If a decision is made to invite a preliminary application the applicant s will be sent a link to the form on e grants Preliminary applications will be reviewed and shortlisted by the Translation Fund Committee Following triage shortlisted applicants will be invited to submit a full application and will be subject to international peer review and due diligence by members of our Technology Transfer Advisory Group TTAG Applicants will be expected to make a presentation on their proposal to the TFC Unless otherwise advised this will be at the next scheduled meeting of the TFC Proposals are taken forward by invitation only Uninvited applications will not be considered The Wellcome Trust website has more detail see Application

    Original URL path: http://isis-innovation.com/award-details/wellcome-trust-translation-fund/ (2016-05-01)
    Open archived version from archive

  • Seeding Drug Discovery - Isis Innovation
    Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Seeding Drug Discovery Share this Seeding Drug Discovery The aim is to develop drug like small molecules to be the springboard for further research and development by the biotechnology and pharmaceutical industry in areas of unmet medical need The two point entry system enables earlier stage projects to be competitive for funding and progresses later stage projects further towards clinical trials Seeding Drug Discovery Key points focus Funding to facilitate early stage small molecule drug discovery The awards help applicants with a potential drug target or new chemistry embark on a programme of compound discovery and or take later stage projects towards clinical trials Projects must address an unmet need in healthcare or in applied medical research offer a potential new solution and have a realistic expectation that the innovation will be developed further by the market Other comments Eligible institutions are not for profit research institutions including those funded by the Medical Research Council Cancer Research UK and Biotechnology and Biological Sciences Research Council in the UK that are able to sign up to the Grant Conditions Applications Procedure Download a Preliminary Application Form Forms and Guidance tab from the Wellcome Trust website or from the mirrored HIC Fund website Completed application forms should be emailed to hicfundapplications hicfund org uk before 13 00 on the relevant closing date Preliminary applications are subject to shortlisting by the Joint Funding Panel JFP for progression to the full application stage Full applications will be invited after the shortlisting meeting Applicants may submit their applications at any time but all applications will be collated and processed in batches beginning the day after each preliminary application closing date Proposals received after a preliminary application closing date will be processed with the subsequent batch All full applications undergo independent peer review Applicants will receive the peer reviewers comments and are invited to respond in writing All shortlisted applicants must present their project proposal in person to the JFP at a funding committee meeting held at the London office of the Wellcome Trust The interview takes the form of a short presentation followed by a question and answer session Applicants will be notified of the JFP s funding decision within seven days of the committee meeting Type of fund Other

    Original URL path: http://isis-innovation.com/award-details/seeding-drug-discovery/ (2016-05-01)
    Open archived version from archive

  • Health Innovation Challenge Fund - Isis Innovation
    Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Health Innovation Challenge Fund Share this Health Innovation Challenge Fund Parallel funding partnership between the Wellcome Trust and the Department of Health to stimulate the creation of innovative healthcare products technologies and interventions and to facilitate their development for the benefit of patients in the NHS and beyond Health Innovation Challenge Fund Key points focus Objectives stimulate the development and uptake of innovative products technologies and interventions for the benefit of patients in the NHS and other healthcare systems and to accelerate the clinical application of projects that are well advanced along the development pathway support UK led projects that target unmet or poorly met healthcare needs provide translational funding for projects that have demonstrated proof of principle and have the potential for clinical use or adoption within five

    Original URL path: http://isis-innovation.com/award-details/health-innovation-challenge-fund/ (2016-05-01)
    Open archived version from archive

  • Health Innovation Challenge Fund: Biological Therapeutics - Isis Innovation
    Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home For University Members Translational funding Health Innovation Challenge Fund Biological Therapeutics Share this Health Innovation Challenge Fund Biological Therapeutics Proposals are invited for biological therapies for non cancerous diseases that are on the fast track towards clinical testing These are drugs of the future to help treat many rare and severe diseases and in particular provide an important advance in the treatment of inflammatory disease Health Innovation Challenge Fund Biological Therapeutics Key points focus Biological therapeutics are the drugs of the future These medicines help treat many rare and severe diseases including heart attacks stroke multiple sclerosis diabetes rheumatoid arthritis and other autoimmune diseases In the past ten years biologics in general have accounted for one third of new medicine approvals Biological drugs in particular have provided an important advance in the treatment of inflammatory disease such as rheumatoid arthritis juvenile idiopathic arthritis ankylosing spondylitis psoriatic arthritis psoriasis Crohn s disease and ulcerative colitis The HICF is seeking proposals for biological therapies for non cancerous diseases that are on the fast track towards the clinical testing For example these could include therapeutic proteins such as signalling substances enzymes and monoclonal antibodies for treating immune disorders infections and other diseases excluding cancer This may include but are not limited to bi specific mAbs multi specific fusion proteins peptides antibody conjugates synthetic antibodies aptamers DNA RNA or microRNA based therapies including gene therapy and antisense therapy cell based therapies therapeutic vaccines unrelated to cancer Specifically out of scope for this call are anti cancer therapeutics biologics used to prevent or diagnose disease tissue engineering based regenerative therapies Other comments All proposals must meet the essential requirements of the HICF scheme and address at least one of its specific themes addressing either a single theme within the current call or spanning several themes Project teams must contain strong clinical representation and will preferably be clinically led Projects must advance to first testing in man within the duration of the

    Original URL path: http://isis-innovation.com/award-details/health-innovation-challenge-fund-biological-therapeutics/ (2016-05-01)
    Open archived version from archive



  •